Your browser doesn't support javascript.
loading
A predictor model of treatment resistance in schizophrenia using data from electronic health records.
Kadra-Scalzo, Giouliana; Fonseca de Freitas, Daniela; Agbedjro, Deborah; Francis, Emma; Ridler, Isobel; Pritchard, Megan; Shetty, Hitesh; Segev, Aviv; Casetta, Cecilia; Smart, Sophie E; Morris, Anna; Downs, Johnny; Christensen, Søren Rahn; Bak, Nikolaj; Kinon, Bruce J; Stahl, Daniel; Hayes, Richard D; MacCabe, James H.
Afiliação
  • Kadra-Scalzo G; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Fonseca de Freitas D; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Agbedjro D; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.
  • Francis E; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Ridler I; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Pritchard M; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Shetty H; South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Segev A; South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Casetta C; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Smart SE; Shalvata Mental Health Center, Hod Hasharon, Israel.
  • Morris A; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Downs J; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Christensen SR; South London and Maudsley NHS Foundation Trust, London, United Kingdom.
  • Bak N; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Kinon BJ; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom.
  • Stahl D; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • Hayes RD; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
  • MacCabe JH; H. Lundbeck A/S, Copenhagen, Denmark.
PLoS One ; 17(9): e0274864, 2022.
Article em En | MEDLINE | ID: mdl-36121864
ABSTRACT

OBJECTIVES:

To develop a prognostic tool of treatment resistant schizophrenia (TRS) in a large and diverse clinical cohort, with comprehensive coverage of patients using mental health services in four London boroughs.

METHODS:

We used the Least Absolute Shrinkage and Selection Operator (LASSO) for time-to-event data, to develop a risk prediction model from the first antipsychotic prescription to the development of TRS, using data from electronic health records.

RESULTS:

We reviewed the clinical records of 1,515 patients with a schizophrenia spectrum disorder and observed that 253 (17%) developed TRS. The Cox LASSO survival model produced an internally validated Harrel's C index of 0.60. A Kaplan-Meier curve indicated that the hazard of developing TRS remained constant over the observation period. Predictors of TRS were having more inpatient days in the three months before and after the first antipsychotic, more community face-to-face clinical contact in the three months before the first antipsychotic, minor cognitive problems, and younger age at the time of the first antipsychotic.

CONCLUSIONS:

Routinely collected information, readily available at the start of treatment, gives some indication of TRS but is unlikely to be adequate alone. These results provide further evidence that earlier onset is a risk factor for TRS.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido